RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
 Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Health Channel

subscribe to Health newsletter
Health

   EMAIL   |   PRINT
Mentor to Present Long-Term Data Supporting Silicone Gel Breast Implants

Apr 13, 2005 - 7:29:00 PM
"It's important to note that there are differences among breast implants as well as among the studies that support their safety and efficacy. We believe the advisory panel will weigh the scientific evidence and find that Mentor's silicone gel-filled implants are an important and safe option for women."

 
[RxPG] Mentor Corporation, a leading supplier of medical products in the United States and internationally, announced this evening that they are looking forward to presenting tomorrow, among other data, up to 12 years of evidence supporting the integrity of Mentor's Memory Gel(TM) silicone gel-filled breast implants. Mentor Corporation will be presenting to the General and Plastic Surgery Panel of the Medical Devices Advisory Committee on April 13, 2005, the third and final day of the advisory panel meeting.

"It's important to note that there are differences among breast implants as well as among the studies that support their safety and efficacy," said Joshua H. Levine, President and Chief Executive Officer of Mentor Corporation. "We believe the advisory panel will weigh the scientific evidence and find that Mentor's silicone gel-filled implants are an important and safe option for women."

Today, the General and Plastic Surgery Panel of the Medical Devices Advisory Committee voted 5 to 4 to recommend non-approval of Inamed's silicone gel-filled breast implants. The panel stated that Inamed failed to adequately address the issues outlined in the Food and Drug Administration's January 2004 Revised Guidance Document.



Publication: Mentor Corporation
On the web: http://www.mentorcorp.com 

Advertise in this space for $10 per month. Contact us today.


Related Health News


Subscribe to Health Newsletter

Enter your email address:


 Additional information about the news article
About Mentor Corporation

Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global healthcare market. The Company develops, manufactures and markets innovative, science-based products for the aesthetics, urologic specialties and clinical and consumer healthcare markets around the world. The Company's website is www.mentorcorp.com.

Safe Harbor Statement

All statements included or incorporated by reference in this release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by us. Forward-looking statements can often be identified by words or phrases such as "anticipates," "scheduled," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "is confident," "may," "will," "should," "would," "could," "potential," "in the future," "continue," similar expressions, and variations or negatives of these words. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements speak only as of the date hereof and are based upon the information available to us at this time. Such information is subject to change, and we will not necessarily inform you of such changes. These statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statement as a result of various factors.

The Securities and Exchange Commission filings of Mentor, including, without limitation, its Annual Reports on Form 10-K, subsequent quarterly reports on Form 10-Q, and recent Current Reports on Form 8-K, discuss important risk factors that could contribute to such differences or otherwise affect its business, results of operations and financial condition. Mentor undertakes no obligation to revise or update publicly any forward-looking statement for any reason.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)